Bausch + Lomb Cost of Goods Sold 2021-2024 | BLCO

Bausch + Lomb annual/quarterly cost of goods sold history and growth rate from 2021 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
  • Bausch + Lomb cost of goods sold for the quarter ending September 30, 2024 was $0.464B, a 18.37% increase year-over-year.
  • Bausch + Lomb cost of goods sold for the twelve months ending September 30, 2024 was $1.832B, a 14.43% increase year-over-year.
  • Bausch + Lomb annual cost of goods sold for 2023 was $1.642B, a 8.1% increase from 2022.
  • Bausch + Lomb annual cost of goods sold for 2022 was $1.519B, a 3.54% increase from 2021.
  • Bausch + Lomb annual cost of goods sold for 2021 was $1.467B, a 14.16% increase from 2020.
Bausch + Lomb Annual Cost of Goods Sold
(Millions of US $)
2023 $1,642
2022 $1,519
2021 $1,467
2020 $1,285
Bausch + Lomb Quarterly Cost of Goods Sold
(Millions of US $)
2024-09-30 $464
2024-06-30 $483
2024-03-31 $424
2023-12-31 $461
2023-09-30 $392
2023-06-30 $417
2023-03-31 $372
2022-12-31 $420
2022-09-30 $372
2022-06-30 $379
2022-03-31 $348
2021-12-31 $403
2021-09-30 $364
2021-06-30 $367
2021-03-31 $333
2020-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $6.881B $4.146B
Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R). Bausch Lomb Corporation is based in VAUGHAN, ON.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $95.766B 11.88
Cencora (COR) United States $49.023B 18.08
DiDi Global (DIDIY) China $23.330B 0.00
ICON (ICLR) Ireland $17.511B 15.60
Natera (NTRA) United States $16.712B 0.00
Viatris (VTRS) United States $15.433B 4.75
Avantor (AVTR) United States $14.831B 22.24
Revvity (RVTY) United States $14.647B 25.44
BioMerieux (BMXMF) France $12.894B 0.00
CochLear (CHEOY) Australia $12.739B 0.00
Solventum (SOLV) United States $12.214B 0.00
Medpace Holdings (MEDP) United States $11.215B 31.59
Charles River Laboratories (CRL) United States $11.042B 21.34
Doximity (DOCS) United States $10.778B 63.79
HealthEquity (HQY) United States $8.750B 47.49
Sonic Healthcare (SKHHY) Australia $8.450B 0.00
Life Times (LTH) United States $5.005B 33.12
Sotera Health (SHC) United States $4.402B 23.55
Organon (OGN) United States $4.012B 4.05
Surgery Partners (SGRY) United States $3.759B 42.85
BrightSpring Health Services (BTSG) United States $3.402B 72.37
PACS (PACS) United States $3.129B 0.00
Concentras Parent (CON) United States $2.579B 0.00
Alignment Healthcare (ALHC) United States $2.523B 0.00
Ardent Health Partners (ARDT) United States $2.446B 0.00
Premier (PINC) United States $2.301B 11.48
GeneDx Holdings (WGS) United States $2.113B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GoodRx Holdings (GDRX) United States $1.783B 47.00
Teladoc Health (TDOC) United States $1.670B 0.00
Progyny (PGNY) United States $1.551B 29.62
Pediatrix Medical (MD) United States $1.331B 13.02
CareDx (CDNA) United States $1.251B 0.00
Establishment Labs Holdings (ESTA) $1.184B 0.00
AMN Healthcare Services Inc (AMN) United States $0.993B 6.72
Embecta (EMBC) United States $0.898B 5.99
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
InnovAge Holding (INNV) United States $0.778B 0.00
Agilon Health (AGL) United States $0.770B 0.00
SBC Medicals (SBC) United States $0.717B 0.00
Auna S.A (AUNA) Luxembourg $0.510B 0.00
Sonida Senior Living (SNDA) United States $0.442B 0.00
DocGo (DCGO) United States $0.426B 16.00
Enhabit (EHAB) United States $0.383B 33.09
COMPASS Pathways (CMPS) United Kingdom $0.346B 0.00
LifeMD (LFMD) United States $0.310B 0.00
ModivCare (MODV) United States $0.244B 13.24
Sera Prognostics (SERA) United States $0.242B 0.00
Beauty Health (SKIN) United States $0.211B 0.00
Nutex Health (NUTX) United States $0.204B 0.00
Biodesix (BDSX) United States $0.204B 0.00
MultiPlan (MPLN) United States $0.141B 0.00
Ascend Wellness Holdings (AAWH) United States $0.120B 0.00
So-Young (SY) China $0.073B 17.77
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.054B 0.00
OncoCyte (OCX) United States $0.051B 0.00
NeueHealth (NEUE) United States $0.042B 1.12
Co-Diagnostics (CODX) United States $0.037B 0.00
Pheton Holdings (PTHL) China $0.029B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
IceCure Medical (ICCM) Israel $0.027B 0.00
Oncology Institute (TOI) United States $0.022B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00